Efficacy and Safety of Bosutinib After Failed TKI in Advanced Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Efficacy and Safety of Bosutinib in Patients With Advanced Leukemia Following Resistance/Intolerance to Imatinib and Other Tyrosine Kinase Inhibitors
Am. J. Hematol 2015 Jun 01;[EPub Ahead of Print], C Gambacorti-Passerini, HM Kantarjian, DW Kim, HJ Khoury, AG Turkina, TH Brümmendorf, E Matczak, N Bardy-Bouxin, M Shapiro, K Turnbull, E Leip, JE CortesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.